These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
339 related items for PubMed ID: 8607497
1. Steroid therapy of chronic hepatitis: characteristics associated with response in anti-hepatitis C virus-positive and -negative patients. Thiele DL, DuCharme L, Cunningham MR, Mimms LT, Cuthbert JA, Lee WM, Combes B. Am J Gastroenterol; 1996 Feb; 91(2):300-8. PubMed ID: 8607497 [Abstract] [Full Text] [Related]
2. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases. Bayraktar Y, Bayraktar M, Gurakar A, Hassanein TI, Van Thiel DH. Hepatogastroenterology; 1997 Feb; 44(14):417-25. PubMed ID: 9164512 [Abstract] [Full Text] [Related]
3. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy. Mazzaro C, Carniello GS, Colle R, Doretto P, Mazzi G, Crovatto M, Santini GF, Tulissi P, Gregoretti M, Mazzoran L, Russo A, Silvestri F, Pozzato G. Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189 [Abstract] [Full Text] [Related]
4. Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy. Mazzaro C, Franzin F, Tulissi P, Pussini E, Crovatto M, Carniello GS, Efremov DG, Burrone O, Santini G, Pozzato G. Cancer; 1996 Jun 15; 77(12):2604-13. PubMed ID: 8640712 [Abstract] [Full Text] [Related]
5. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus]. Wu CH, Xu XY, Tian GS, Yu YY. Zhonghua Yi Xue Za Zhi; 2006 Feb 14; 86(6):390-3. PubMed ID: 16677548 [Abstract] [Full Text] [Related]
6. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection. Weiland O, Chen M, Lindh G, Mattsson L, Schvarcz R, Sönnerborg A, Wahl M, Wejstål R, Widell A, Norkrans G. Scand J Infect Dis; 1995 Feb 14; 27(4):319-24. PubMed ID: 8658063 [Abstract] [Full Text] [Related]
7. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Cacoub P, Lidove O, Maisonobe T, Duhaut P, Thibault V, Ghillani P, Myers RP, Leger JM, Servan J, Piette JC. Arthritis Rheum; 2002 Dec 14; 46(12):3317-26. PubMed ID: 12483738 [Abstract] [Full Text] [Related]
8. [Autoimmune hepatitis and/or hepatitis C]. Simonović J, Dokić Lj, Svirtlih N, Djordjević M, Bozić N, Poluga J. Srp Arh Celok Lek; 1999 Dec 14; 127(3-4):109-13. PubMed ID: 10500434 [Abstract] [Full Text] [Related]
15. Prospective comparison of four lymphoblastoid interferon alpha schedules for chronic hepatitis C. A multivariate analysis of factors predictive of sustained response to treatment. Bellobuono A, Mondazzi L, Tempini S, Silini E, Idéo G. Eur J Gastroenterol Hepatol; 1997 Dec 14; 9(12):1169-77. PubMed ID: 9471022 [Abstract] [Full Text] [Related]
19. Assessment of specific antibodies to F protein in serum samples from Chinese hepatitis C patients treated with interferon plus ribavarin. Gao DY, Zhang XX, Hou G, Jin GD, Deng Q, Kong XF, Zhang DH, Ling Y, Yu DM, Gong QM, Zhan Q, Yao BL, Lu ZM. J Clin Microbiol; 2008 Nov 14; 46(11):3746-51. PubMed ID: 18832124 [Abstract] [Full Text] [Related]